Dr Hwang reviews key findings of research he presented at ACR Convergence on inflammatory back pain and the importance of multimodality evaluation to identify patients with axial spondyloarthritis vs mechanical back pain.
Dr Hwang reviews key findings of research he presented at ACR Convergence on inflammatory back pain and the importance of multimodality evaluation to identify patients with axial spondyloarthritis vs mechanical back pain.
An 8-week individualized training program led to significant improvements in trunk function and aerobic capacity in patients with axSpA, offering rheumatologists new data to support exercise-based interventions.
An 8-week individualized training program led to significant improvements in trunk function and aerobic capacity in patients with axSpA, offering rheumatologists new data to support exercise-based interventions.
A phase III randomized trial showed QX002N significantly improved clinical outcomes and MRI-assessed inflammation in patients with radiographic axSpA, with a favorable safety profile.
A phase III randomized trial showed QX002N significantly improved clinical outcomes and MRI-assessed inflammation in patients with radiographic axSpA, with a favorable safety profile.
Dr Karmacharya reviews his presentation from ACR Convergence a population-based study from the UK THIN database across psoriatic arthritis, psoriasis, and axial spondyloarthritis to find distinct and remarkably stable patterns of...
Dr Karmacharya reviews his presentation from ACR Convergence a population-based study from the UK THIN database across psoriatic arthritis, psoriasis, and axial spondyloarthritis to find distinct and remarkably stable patterns of...
Understanding the specific strengths and weaknesses of imaging modalities such as CT, MRI, and x-ray, is critical for the accurate diagnosis and monitoring of axSpA, a new review concludes.
Understanding the specific strengths and weaknesses of imaging modalities such as CT, MRI, and x-ray, is critical for the accurate diagnosis and monitoring of axSpA, a new review concludes.
Korean researchers found that patients with axial spondyloarthritis who were treated with increasing doses of nonsteroidal anti-inflammatory drugs were at higher risk of heart disease.
Korean researchers found that patients with axial spondyloarthritis who were treated with increasing doses of nonsteroidal anti-inflammatory drugs were at higher risk of heart disease.
